D. Greene

发表

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Distal neuropathy in experimental diabetes mellitus

D. Greene, Mark J. Brown, A. Sumner, 1980, Annals of neurology.

Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects.

J C Arezzo, J. Arezzo, M. Pfeifer, 1995, Journal of diabetes and its complications.

An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

D. Greene, M. Stevens, Xianghui Cao, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Digital electron microscopic examination of human sural nerve biopsies

D. Greene, K. A. Sullivan, M. S. Brown, 2003, Journal of the peripheral nervous system : JPNS.

Receptor‐Coupled Phosphoinositide Hydrolysis in Human Retinal Pigment Epithelium

G. C. Johnston, E. Feldman, D. Greene, 1991, Journal of neurochemistry.

Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

D. Greene, M. Stevens, A. Sima, 1996, The Journal of clinical investigation.

Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

D. Greene, V. Bril, A. Sima, 1988, The Journal of clinical investigation.

Complications: Neuropathy, Pathogenetic Considerations

E. Feldman, D. Greene, M. Stevens, 1992, Diabetes Care.

The pathogenesis and prevention of diabetic neuropathy and nephropathy.

D. Greene, 1988, Metabolism: clinical and experimental.

Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.

S. Yagihashi, D. Greene, A. Sima, 1986, The Journal of clinical investigation.

Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man.

K. Eriksson, L. Dahlin, G. Sundkvist, 2003, Diabetes.

Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells.

D. Greene, M. Stevens, P. Killen, 1993, The American journal of physiology.

In Vitro Studies of the Substrates for Energy Production and the Effects of Insulin on Glucose Utilization in the Neural Components of Peripheral Nerve

D. Greene, A. Winegrad, 1979, Diabetes.

Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy.

E. Feldman, D. Greene, M. Stevens, 1999, European journal of pharmacology.

Endoneurial Microvessels in Human Diabetic Neuropathy: Endothelial Cell Dysjunction and Lack of Treatment Effect by Aldose Reductase Inhibitor

D. Greene, V. Bril, A. Prashar, 1991, Diabetes.

Protein kinase and Ca2+ modulation of myo-inositol transport in cultured retinal pigment epithelial cells.

A. Karihaloo, D. Greene, K. Kato, 1997, The American journal of physiology.

Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial

M. B. Brown, J. Albers, D. Greene, 1996, Neurology.

Diabetic and hypoglycemic neuropathy--a comparison in the BB rat.

D. Greene, A. Sima, Weixian Zhang, 1989, Diabetes research and clinical practice.

Evaluation of α1‐adrenoceptor antagonist on diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

D. Greene, M. Stevens, Xianghui Cao, 2000 .

Evaluation of a 1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function , metabolism , and antioxidative defense

D. Greene, M. Stevens, Xianghui Cao, 2000 .

Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-α-lipoic acid

D. Greene, M. Stevens, Xianghui Cao, 1998, Diabetologia.

The Aetiology of Diabetic Neuropathy: the Combined Roles of Metabolic and Vascular Defects

E. Feldman, D. Greene, M. Stevens, 1995, Diabetic medicine : a journal of the British Diabetic Association.

Sorbitol and myo‐inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance

G. Sundkvist, D. Greene, A. Sima, 2000, Diabetic medicine : a journal of the British Diabetic Association.

Acute effects of adrenergic-mediated ischemia on nerve conduction in subjects with type 2 diabetes.

J. Halter, E. Feldman, D. Greene, 1999, Metabolism: clinical and experimental.

2-Chloroadenosine reverses hyperglycemia-induced inhibition of phosphoinositide synthesis in cultured human retinal pigment epithelial cells and prevents reduced nerve conduction velocity in diabetic rats.

D. Greene, M. Stevens, J. Nakamura, 1999, Metabolism: clinical and experimental.

In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists.

D. Greene, A. Sima, S. Lattimer, 1989, The American journal of physiology.

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.

M. B. Brown, D. Greene, V. Bril, 1988, The New England journal of medicine.

Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.

D. Greene, A. Sima, S. Lattimer-Greene, 1989, Critical reviews in neurobiology.

Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat.

S. Yagihashi, D. Greene, A. Sima, 1984, The American journal of physiology.

Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve.

D. Greene, S. Lattimer, 1984, The American journal of physiology.

Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.

D. Greene, S. Lattimer, 1983, The Journal of clinical investigation.

Glutathione Redox State Is Not the Link Between Polyol Pathway Activity and Myo-Inosltol–Related Na+-K+-ATPase Defect in Experimental Diabetic Neuropathy

D. Greene, P. Carroll, B. M. Thornton, 1986, Diabetes.

Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function.

D. Greene, 1983, Metabolism: clinical and experimental.

Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.

D. Greene, A. Sima, S. Lattimer, 1987, The Journal of clinical investigation.

Action of Sorbinil in Diabetic Peripheral Nerve: Relationship of Polyol (Sorbitol) Pathway Inhibition to a myo-Inositol-mediated Defect in Sodium-Potassium ATPase Activity

D. Greene, S. Lattimer, 1984, Diabetes.

Pathogenesis of diabetic neuropathy.

E. Feldman, D. Greene, M. Stevens, 1989, Clinical neuroscience.

Normalization of Na+-K+-ATPase Activity in Isolated Membrane Fraction From Sciatic Nerves of Streptozocin-Induced Diabetic Rats by Dietary myo-Inositol Supplementation in Vivo or Protein Kinase C Agonists in Vitro

D. Greene, H. Kyriazi, Jean Kim, 1991, Diabetes.

Effects of Acute Experimental Diabetes on Composite Energy Metabolism in Peripheral Nerve Axons and Schwann Cells

D. Greene, A. Winegrad, 1981, Diabetes.

Polyol Pathway Activity and Myo-Inositol Metabolism: A Suggested Relationship in the Pathogenesis of Diabetic Neuropathy

D. Finegold, D. Greene, S. Lattimer, 1983, Diabetes.

Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells.

D. Greene, J. Nakamura, D. Shewach, 1992, The American journal of physiology.

Noninvasive Assessment of Cardiac Diabetic Neuro . - JiTi.f by Carbora-11 Hydroxyephee_LT_ i-nd Positron Emission Tomography

G. Hutchins, M. Schwaiger, K. Allman, 2016 .

Diabetic Autonomic Neuropathy in BB Rats and Effect of ARI Treatment on Heart-Rate Variability and Vagus Nerve Structure

S. Chakrabarti, D. Greene, A. Sima, 1990, Diabetes.

Alternate splicing in human Na+-MI cotransporter gene yields differentially regulated transport isoforms.

A. Karihaloo, M. Togawa, F. Porcellati, 1999, American journal of physiology. Cell physiology.

Alternate splicing in human Na+-MI cotransporter gene yields differentially regulated transport isoforms.

A. Karihaloo, M. Togawa, F. Porcellati, 1999, The American journal of physiology.

Insulinoma in a 94-year-old Woman: Long-term Therapy with Verapamil

J. Ulbrecht, D. Greene, R. Schmeltz, 1986, Diabetes Care.

Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

D. Greene, M. Stevens, Xianghui Cao, 2000, Diabetes.

Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells.

D. Greene, P. Killen, M. D. Del Monte, 1993, The Journal of clinical investigation.

Effects of DL-a-Lipoic Acid on Peripheral Nerve Conduction, Blood Flow, Energy Metabolism, and Oxidative Stress in Experimental Diabetic Neuropathy

D. Greene, M. Stevens, Xianghui Cao, 2000 .

Regulation of the human taurine transporter by oxidative stress in retinal pigment epithelial cells stably transformed to overexpress aldose reductase.

R. Pop-Busui, E. Nakashima, D. Greene, 2005, Antioxidants & redox signaling.

Effects of aldose reductase inhibitors on the progression of nerve fiber damage in diabetic neuropathy.

D. Greene, 1992, Journal of diabetes and its complications.

Human Na+- myo-inositol cotransporter gene: alternate splicing generates diverse transcripts.

T. Glover, M. Togawa, F. Porcellati, 1998, American journal of physiology. Cell physiology.

Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells.

W. Sherman, F. Porcellati, D. Greene, 1994, The Journal of clinical investigation.

Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3.

G. Gould, D. Greene, A. Sima, 1996, Metabolism: clinical and experimental.

A defect in sodium-dependent amino acid uptake in diabetic rabbit peripheral nerve. Correction by an aldose reductase inhibitor or myo-inositol administration.

D. Finegold, D. Greene, J. Fernstrom, 1990, The Journal of clinical investigation.

Comparison of Clinical Course and Sequential Electrophysiological Tests in Diabetics with Symptomatic Polyneuropathy and its Implications for Clinical Trials

D. Greene, S. Braunstein, S. Schwartz, 1981, Diabetes.

Human Na(+)-myo-inositol cotransporter gene: alternate splicing generates diverse transcripts.

T. Glover, M. Togawa, F. Porcellati, 1998, The American journal of physiology.

Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat

D. Greene, M. Stevens, A. Sima, 1993, Diabetologia.

Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.

D. Greene, S. Lattimer, 1985, The American journal of medicine.

The Polyol Pathway in Dysfunction of Diabetic Peripheral Nerve

D. Greene, S. Lattimer, 1985, Diabetic medicine : a journal of the British Diabetic Association.

Altered Nerve Myo-Inositol Metabolism in Experimental Diabetes and Its Relationship to Nerve Function

D. Greene, S. Lattimer, 1985 .

RABBIT SCIATIC NERVE FASCICLE AND‘ENDONEURIAL’PREPARATIONS FOR IN VITRO STUDIES OF PERIPHERAL NERVE GLUCOSE METABOLISM

L. Orci, J. Carpentier, D. Greene, 1979, Journal of neurochemistry.

Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.

R. Pop-Busui, D. Greene, M. Stevens, 2002, Diabetes.

An alteration in internodal myelin membrane structure in large sciatic nerve fibres in rats with acute streptozotocin diabetes and impaired nerve conduction velocity

L. Orci, J. Carpentier, D. Greene, 1978, Diabetologia.

Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.

D. Greene, S. Lattimer, 1982, The Journal of clinical investigation.

Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study

E. Bass, L. Kuller, J. Dorman, 1989, Diabetes.

Structural‐Functional Interactions in the Therapeutic Response of Diabetic Neuropathy

D. Greene, A. Sima, A. Sima, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.

S. Chakrabarti, D. Greene, A. Sima, 1990, The Journal of clinical investigation.

The complications of diabetes mellitus.

D. Greene, A. Winegrad, 1978, The New England journal of medicine.

Supplemental myo-Inositol Prevents L-Fucose–Induced Diabetic Neuropathy

R. Lightle, J. Dunlap, E. Davidson, 1997, Diabetes.

Reduced Motor Nerve Conduction Velocity and Na+-K+-ATPase Activity in Rats Maintained on L-Fucose Diet: Reversal by myo-Inositol Supplementation

J. Dunlap, E. Davidson, M. Yorek, 1993, Diabetes.

Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid.

D. Greene, I. Obrosova, L. Fathallah, 2000, European journal of pharmacology.

A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy

M B Brown, M. B. Brown, Morton B. Brown, 1994, Diabetes Care.

Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.

D. Greene, A. Winegrad, P. D. de Jesus, 1975, The Journal of clinical investigation.

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.

D. Greene, A. Sima, S. Lattimer, 1987, The New England journal of medicine.

A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.

D. Greene, 1986, Metabolism: clinical and experimental.

Sorbitol, myo-Inositol, and Rod Outer Segment Phagocytosis in Cultured hRPE Cells Exposed to Glucose: In Vitro Model of myo-Inositol Depletion Hypothesis of Diabetic Complications

D. Greene, J. Nakamura, R. Rabbani, 1991, Diabetes.

Sorbitol, Myo-Inositol and Sodium-Potassium ATPase in Diabetic Peripheral Nerve

D. Greene, 2012, Drugs.

Pathogenesis and prevention of diabetic neuropathy.

D. Greene, A. Sima, S. Lattimer, 1988, Diabetes/metabolism reviews.

Altered Sorbitol and myo‐Inositol Metabolism as the Basis for Defective Protein Kinase C and (Na,K)‐ATPase Regulation in Diabetic Neuropathy a

D. Greene, S. Lattimer, 1986, Annals of the New York Academy of Sciences.

Decreased Myo-Inositol Content and Na+-K+-ATPase Activity in Superior Cervical Ganglion of STZ-Diabetic Rat and Prevention by Aldose Reductase Inhibition

D. Greene, A. M. Mackway, 1986, Diabetes.

A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: Relationship to myo-inositol metabolism and nerve conduction slowing

D. Greene, 1986 .

Glucose-induced Alterations in Nerve Metabolism: Current Perspective on the Pathogenesis of Diabetic Neuropathy and Future Directions for Research and Therapy

J. Ulbrecht, D. Greene, S. Lattimer, 1985, Diabetes Care.

Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.

E. Feldman, D. Greene, M. Stevens, 1993, Diabetes/metabolism reviews.

Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis.

D. Greene, A. Winegrad, 1976, The New England journal of medicine.

Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes.

D. Moller, D. Greene, 2001, Advances in protein chemistry.

Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat.

E. Feldman, D. Millington, D. Greene, 1996, Metabolism: clinical and experimental.

Pittsburgh Epidemiology of Diabetes Complications Study: Measuring Diabetic Neuropathy Follow-up Study Results

L. Kuller, T. Orchard, D. Becker, 1992, Diabetes Care.

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy

M. B. Brown, Morton B. Brown, J. Arezzo, 1999, Neurology.

Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT)

Morton B. Brown, J. Albers, D. Greene, 1996, Muscle & nerve.

Overt Diabetic Neuropathy: Repair of Axo‐glial Dysjunction and Axonal Atrophy by Aldose Reductase Inhibition and its Correlation to Improvement in Nerve Conduction Velocity

D. Greene, V. Bril, A. Prashar, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Single‐fiber electromyography in diabetic peripheral polyneuropathy

D. Greene, V. Bril, A. Sima, 1996, Muscle & nerve.

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

E. Feldman, D. Greene, M. Stevens, 1994, The Journal of clinical investigation.

Diabetic neuropathy.

J. Albers, M. Pfeifer, D. Greene, 1990, Annual review of medicine.

Are Disturbances of Sorbitol, Phosphoinositide, and Na+-K+-ATPase Regulation Involved in Pathogenesis of Diabetic Neuropathy?

D. Greene, A. Sima, S. Lattimer, 1988, Diabetes.

Clinical Management of Diabetic Neuropathy

E. Feldman, D. Greene, M. Stevens, 1998 .

Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study

D. Greene, H. Lang, I. Obrosova, 1999, Diabetologia.

Diminished Specific Activity of Cytosolic Protein Kinase C In Sciatic Nerve of Streptozocin-Induced Diabetic Rats and Its Correction by Dietary myo-Inositol

B. Agranoff, T. Ueda, D. Greene, 1991, Diabetes.

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

James Albers, Eva L Feldman, J. Albers, 2006, Diabetes care.

Diabetic neuropathy: scope of the syndrome.

E. Feldman, D. Greene, M. Stevens, 1999, The American journal of medicine.

Selective Effects of Myo-inositol Administration on Sciatic and Tibial Motor Nerve Conduction Parameters in the Streptozocin-Diabetic Rat

D. Greene, M. J. Brown, S. Lattimer, 1982, Diabetes.

Abnormal Agonist-Stimulated Cardiac Parasympathetic Acetylcholine Release in Streptozocin-Induced Diabetes

A. Manto, G. Ghirlanda, D. Greene, 1993, Diabetes.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Improving diabetes processes of care in managed care.

W. Herman, D. Greene, Catherine L. Martin, 2003, Diabetes care.

Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells.

A. Karihaloo, D. Greene, M. Stevens, 1996, The Journal of clinical investigation.

Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography.

G. Hutchins, M. Schwaiger, K. Allman, 1993, Journal of the American College of Cardiology.

A Multicenter Study on the Prevalence of Diabetic Neuropathy in Italy

D. Cucinotta, G. Comi, E. Feldman, 1997, Diabetes Care.

Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity.

J. Halter, A. Galecki, B. Pitt, 1998, The Journal of clinical endocrinology and metabolism.

Diabetic Neuropathy in the Elderly

D. Greene, A. F. Sima, A. Sima, 1995, Drugs & aging.

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

B. Zinman, R. Holman, Daniel Levy, 2002, Diabetes care.

Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy

J. Halter, J. Ochoa, J. Albers, 1988, Diabetes.

Protein Kinase C Agonists Acutely Normalize Decreased Ouabain-inhibitable Respiration in Diabetic Rabbit Nerve: Implications for (Na,K)-ATPase Regulation and Diabetic Complications

D. Greene, S. Lattimer, 1986, Diabetes.

The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy

Morton B. Brown, S. Chakrabarti, D. Greene, 1992, Diabetologia.

Diabetic Peripheral Neuropathy

M. Pfeifer, D. Greene, V. Broadstone, 1987 .

Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve

D. Greene, A. Sima, S. Yagihashi, 1987, Diabetologia.

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Reversible and irreversible nodal dysfunction in diabetic neuropathy

T. Brismar, D. Greene, A. Sima, 1987, Annals of neurology.

Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.

D. Greene, A. Sima, T. Hohman, 1993, Journal of diabetes and its complications.

Effect of H perglycemia and the Aldose Reductase nhibitor Tolrestat on Sural Nerve P Biochemistry and MO Diabetic Peripheral hometry in Advanced

Morton B. Brown, D. Greene, T. Hohman, 1993 .

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

J. Keith Jones, A. Paterson, S. Mudaliar, 2018, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.

Diabetic Peripheral Neuropathy Part I: Sensorimotor Neuropathy

M. Pfeifer, D. Greene, V. Broadstone, 1987 .

Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture.

E. Feldman, D. Greene, M. Stevens, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Transphosphatidylation of sugar alcohols and its implications for the pathogenesis of diabetic complications

D. Greene, J. Nakamura, S. Lattimer, 1994, Diabetologia.

Effects of Aldose Reductase Inhibitors on the Progression of Nerve Damage

D. Greene, A. Sima, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

P. Raskin, C. Siu, S. Edelman, 1998, Neurology.

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

P A Cleary, M. Goldbaum, S. Schwartz, 2001, The Journal of pediatrics.

Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.

P. Raskin, W. Olson, S. Edelman, 2000, Journal of diabetes and its complications.

Acute and chronic complications of diabetes mellitus in older patients.

D. Greene, D A Greene, 1986, The American journal of medicine.

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

J. Albers, W. Herman, P. Cleary, 2006, Diabetes care.

Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy.

B. Perkins, D. Greene, V. Bril, 2001, Diabetes care.